205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.84%
Revenue growth at 50-75% of AMD's 20.86%. Martin Whitman would worry about competitiveness or product relevance.
16.44%
Gross profit growth at 50-75% of AMD's 26.83%. Martin Whitman would question if cost structure or brand is lagging.
26.41%
EBIT growth below 50% of AMD's 1204.02%. Michael Burry would suspect deeper competitive or cost structure issues.
13.75%
Operating income growth under 50% of AMD's 1204.02%. Michael Burry would be concerned about deeper cost or sales issues.
0.48%
Net income growth under 50% of AMD's 571.44%. Michael Burry would suspect the firm is falling well behind a key competitor.
2.63%
EPS growth under 50% of AMD's 533.33%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
No Data
No Data available this quarter, please select a different quarter.
-0.55%
Share reduction while AMD is at 0.91%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.36%
Reduced diluted shares while AMD is at 9.35%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-99.94%
Dividend reduction while AMD stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
83.07%
OCF growth 1.25-1.5x AMD's 61.82%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
86.67%
FCF growth under 50% of AMD's 275.29%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-2.77%
Negative 10Y revenue/share CAGR while AMD stands at 38.74%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
20.39%
Positive 5Y CAGR while AMD is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
68.07%
3Y revenue/share CAGR under 50% of AMD's 157.39%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
175.37%
10Y OCF/share CAGR above 1.5x AMD's 111.92%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
228.76%
5Y OCF/share CAGR above 1.5x AMD's 16.82%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
182.00%
3Y OCF/share CAGR under 50% of AMD's 493.74%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
102.53%
Positive 10Y CAGR while AMD is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-1.52%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
253.22%
3Y net income/share CAGR above 1.5x AMD's 125.69%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
186.13%
Positive growth while AMD is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
1.13%
Positive 5Y equity/share CAGR while AMD is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
12.65%
Positive short-term equity growth while AMD is negative. John Neff sees a strong advantage in near-term net worth buildup.
-99.93%
Cut dividends over 10 years while AMD stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-99.92%
Negative 5Y dividend/share CAGR while AMD stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-99.93%
Negative near-term dividend growth while AMD invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
0.68%
AR growth is negative/stable vs. AMD's 17.14%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-3.66%
Inventory is declining while AMD stands at 2.26%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.44%
Asset growth at 50-75% of AMD's 4.98%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
4.15%
BV/share growth above 1.5x AMD's 1.77%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.83%
We’re deleveraging while AMD stands at 5.97%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
6.90%
R&D growth drastically higher vs. AMD's 6.03%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
20.35%
SG&A growth well above AMD's 13.23%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.